Anthrax Vaccines Market Report

Global and Region Anthrax Vaccines Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Aug 01, 2022
  • PAGES：173
  • REPORT CODE：GMM974826
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • Anthrax is a serious infectious disease caused by bacillus anthracis. It is commonly infected through four routes, namely the lungs, intestines, skin and injections. Anthrax affects both humans and animals, especially ruminants such as cattle, sheep, goats and horses. The signs and symptoms of anthrax vary depending on the type of infection. Common symptoms of skin anthrax include rashes, swelling, pain, and itching. Nausea, abdominal pain, loss of appetite, vomiting, fever, bloody diarrhea, neck swelling, headache, and difficulty swallowing are the most common symptoms of gastrointestinal anthrax. Shortness of breath, coughing up blood, pain in swallowing, mild chest discomfort, and nausea are symptoms of inhaled anthrax. Multiple organ failure, meningitis, redness and swelling at the injection site are the most common symptoms. There are two key methods of diagnosing anthrax globally, using the presence of antibodies or toxins in a patient's blood sample. In addition, medical experts recommend direct testing to determine the presence of anthrax in a sample.

    The report details the trend, potential and market size of Anthrax Vaccines market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Anthrax Vaccinesmarket, defines the market attractiveness level of Anthrax Vaccines market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Anthrax Vaccines industry, describes the types of Anthrax Vaccines market, the applications of major players and the market size, and deeply analyzes the current situation of the global Anthrax Vaccines market and the development prospects and opportunities of Anthrax Vaccines industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Anthrax Vaccines market in Chapter 13.

    By Player:

    • Emergent BioSolutions

    • Colorado Serum

    • Indian Immunologicals

    • CAVAC

    • Intervac

    • JOVAC

    • Agrovet

    • Merial

    • Ceva Santé Animale

    • CVCRI

    • Botswana Vaccine Institute

    • Zoetis

    • IVPM

    • Rosenbusch

    • Merck

    • Prondil

    • Biogénesis-Bago

    • Bayer Sanidad Animal

    • PharmAthene

    • Vecol

    • CDV

    • Tiankang

    By Type:

    • Live Vaccines

    • Cell free PA Vaccines

    By End-User:

    • Hospitals

    • Clinics

    • Vaccination Centers

    • Others

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Anthrax Vaccines Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Anthrax Vaccines Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Anthrax Vaccines Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Anthrax Vaccines Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Anthrax Vaccines Market Analysis and Outlook to 2022

    • 7.1 Global Anthrax Vaccines Consumption (2017-2022)

    • 7.2 United States Anthrax Vaccines Consumption (2017-2022)

    • 7.3 Europe Anthrax Vaccines Consumption (2017-2022)

    • 7.4 China Anthrax Vaccines Consumption (2017-2022)

    • 7.5 Japan Anthrax Vaccines Consumption (2017-2022)

    • 7.6 India Anthrax Vaccines Consumption (2017-2022)

    • 7.7 South Korea Anthrax Vaccines Consumption (2017-2022)

    8 Region and Country-wise Anthrax Vaccines Market Analysis and Outlook to 2028

    • 8.1 Global Anthrax Vaccines Consumption Forecast (2022-2028)

    • 8.2 United States Anthrax Vaccines Consumption Forecast (2022-2028)

    • 8.3 Europe Anthrax Vaccines Consumption Forecast (2022-2028)

    • 8.4 China Anthrax Vaccines Consumption Forecast (2022-2028)

    • 8.5 Japan Anthrax Vaccines Consumption Forecast (2022-2028)

    • 8.6 India Anthrax Vaccines Consumption Forecast (2022-2028)

    • 8.7 South Korea Anthrax Vaccines Consumption Forecast (2022-2028)

    9 Global Anthrax Vaccines Market Outlook by Types and Applications to 2022

    • 9.1 Global Anthrax Vaccines Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Live Vaccines Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Cell free PA Vaccines Consumption and Growth Rate (2017-2022)

    • 9.2 Global Anthrax Vaccines Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Hospitals Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Clinics Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Vaccination Centers Consumption and Growth Rate (2017-2022)

      • 9.2.4 Global Others Consumption and Growth Rate (2017-2022)

    10 Global Anthrax Vaccines Market Outlook by Types and Applications to 2028

    • 10.1 Global Anthrax Vaccines Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Live Vaccines Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Cell free PA Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Anthrax Vaccines Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Hospitals Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Clinics Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Vaccination Centers Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.4 Global Others Consumption Forecast and Growth Rate (2022-2028)

    11 Global Anthrax Vaccines Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Anthrax Vaccines Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Anthrax Vaccines Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Anthrax Vaccines Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Anthrax Vaccines Market Competitive Analysis

    • 14.1 Emergent BioSolutions

      • 14.1.1 Emergent BioSolutions Company Details

      • 14.1.2 Emergent BioSolutions Anthrax Vaccines Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Emergent BioSolutions Anthrax Vaccines Product and Service

    • 14.2 Colorado Serum

      • 14.2.1 Colorado Serum Company Details

      • 14.2.2 Colorado Serum Anthrax Vaccines Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 Colorado Serum Anthrax Vaccines Product and Service

    • 14.3 Indian Immunologicals

      • 14.3.1 Indian Immunologicals Company Details

      • 14.3.2 Indian Immunologicals Anthrax Vaccines Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Indian Immunologicals Anthrax Vaccines Product and Service

    • 14.4 CAVAC

      • 14.4.1 CAVAC Company Details

      • 14.4.2 CAVAC Anthrax Vaccines Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 CAVAC Anthrax Vaccines Product and Service

    • 14.5 Intervac

      • 14.5.1 Intervac Company Details

      • 14.5.2 Intervac Anthrax Vaccines Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 Intervac Anthrax Vaccines Product and Service

    • 14.6 JOVAC

      • 14.6.1 JOVAC Company Details

      • 14.6.2 JOVAC Anthrax Vaccines Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 JOVAC Anthrax Vaccines Product and Service

    • 14.7 Agrovet

      • 14.7.1 Agrovet Company Details

      • 14.7.2 Agrovet Anthrax Vaccines Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 Agrovet Anthrax Vaccines Product and Service

    • 14.8 Merial

      • 14.8.1 Merial Company Details

      • 14.8.2 Merial Anthrax Vaccines Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 Merial Anthrax Vaccines Product and Service

    • 14.9 Ceva Santé Animale

      • 14.9.1 Ceva Santé Animale Company Details

      • 14.9.2 Ceva Santé Animale Anthrax Vaccines Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 Ceva Santé Animale Anthrax Vaccines Product and Service

    • 14.10 CVCRI

      • 14.10.1 CVCRI Company Details

      • 14.10.2 CVCRI Anthrax Vaccines Sales, Price, Value and Gross Profit (2017-2022)

      • 14.10.3 CVCRI Anthrax Vaccines Product and Service

    • 14.11 Botswana Vaccine Institute

      • 14.11.1 Botswana Vaccine Institute Company Details

      • 14.11.2 Botswana Vaccine Institute Anthrax Vaccines Sales, Price, Value and Gross Profit (2017-2022)

      • 14.11.3 Botswana Vaccine Institute Anthrax Vaccines Product and Service

    • 14.12 Zoetis

      • 14.12.1 Zoetis Company Details

      • 14.12.2 Zoetis Anthrax Vaccines Sales, Price, Value and Gross Profit (2017-2022)

      • 14.12.3 Zoetis Anthrax Vaccines Product and Service

    • 14.13 IVPM

      • 14.13.1 IVPM Company Details

      • 14.13.2 IVPM Anthrax Vaccines Sales, Price, Value and Gross Profit (2017-2022)

      • 14.13.3 IVPM Anthrax Vaccines Product and Service

    • 14.14 Rosenbusch

      • 14.14.1 Rosenbusch Company Details

      • 14.14.2 Rosenbusch Anthrax Vaccines Sales, Price, Value and Gross Profit (2017-2022)

      • 14.14.3 Rosenbusch Anthrax Vaccines Product and Service

    • 14.15 Merck

      • 14.15.1 Merck Company Details

      • 14.15.2 Merck Anthrax Vaccines Sales, Price, Value and Gross Profit (2017-2022)

      • 14.15.3 Merck Anthrax Vaccines Product and Service

    • 14.16 Prondil

      • 14.16.1 Prondil Company Details

      • 14.16.2 Prondil Anthrax Vaccines Sales, Price, Value and Gross Profit (2017-2022)

      • 14.16.3 Prondil Anthrax Vaccines Product and Service

    • 14.17 Biogénesis-Bago

      • 14.17.1 Biogénesis-Bago Company Details

      • 14.17.2 Biogénesis-Bago Anthrax Vaccines Sales, Price, Value and Gross Profit (2017-2022)

      • 14.17.3 Biogénesis-Bago Anthrax Vaccines Product and Service

    • 14.18 Bayer Sanidad Animal

      • 14.18.1 Bayer Sanidad Animal Company Details

      • 14.18.2 Bayer Sanidad Animal Anthrax Vaccines Sales, Price, Value and Gross Profit (2017-2022)

      • 14.18.3 Bayer Sanidad Animal Anthrax Vaccines Product and Service

    • 14.19 PharmAthene

      • 14.19.1 PharmAthene Company Details

      • 14.19.2 PharmAthene Anthrax Vaccines Sales, Price, Value and Gross Profit (2017-2022)

      • 14.19.3 PharmAthene Anthrax Vaccines Product and Service

    • 14.20 Vecol

      • 14.20.1 Vecol Company Details

      • 14.20.2 Vecol Anthrax Vaccines Sales, Price, Value and Gross Profit (2017-2022)

      • 14.20.3 Vecol Anthrax Vaccines Product and Service

    • 14.21 CDV

      • 14.21.1 CDV Company Details

      • 14.21.2 CDV Anthrax Vaccines Sales, Price, Value and Gross Profit (2017-2022)

      • 14.21.3 CDV Anthrax Vaccines Product and Service

    • 14.22 Tiankang

      • 14.22.1 Tiankang Company Details

      • 14.22.2 Tiankang Anthrax Vaccines Sales, Price, Value and Gross Profit (2017-2022)

      • 14.22.3 Tiankang Anthrax Vaccines Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Anthrax Vaccines

    • Figure Anthrax Vaccines Picture

    • Table Global Anthrax Vaccines Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Anthrax Vaccines Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Anthrax Vaccines Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Anthrax Vaccines Consumption by Country (2017-2022)

    • Figure United States Anthrax Vaccines Consumption and Growth Rate (2017-2022)

    • Table Europe Anthrax Vaccines Consumption and Growth Rate (2017-2022)

    • Figure China Anthrax Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Japan Anthrax Vaccines Consumption and Growth Rate (2017-2022)

    • Figure India Anthrax Vaccines Consumption and Growth Rate (2017-2022)

    • Figure South Korea Anthrax Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Global Anthrax Vaccines Consumption Forecast by Country (2022-2028)

    • Figure United States Anthrax Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Anthrax Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Anthrax Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Anthrax Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Anthrax Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Anthrax Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Live Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Global Cell free PA Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Global Hospitals Consumption and Growth Rate (2017-2022)

    • Figure Global Clinics Consumption and Growth Rate (2017-2022)

    • Figure Global Vaccination Centers Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Live Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Cell free PA Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hospitals Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Clinics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Vaccination Centers Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Anthrax Vaccines Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Anthrax Vaccines Export by Region (Top 5 Countries) (2017-2028)

    • Table Emergent BioSolutions (Foundation Year, Company Profile and etc.)

    • Table Emergent BioSolutions Anthrax Vaccines Sales, Price, Value and Gross Profit (2017-2022)

    • Table Emergent BioSolutions Anthrax Vaccines Product and Service

    • Table Colorado Serum (Foundation Year, Company Profile and etc.)

    • Table Colorado Serum Anthrax Vaccines Sales, Price, Value and Gross Profit (2017-2022)

    • Table Colorado Serum Anthrax Vaccines Product and Service

    • Table Indian Immunologicals (Foundation Year, Company Profile and etc.)

    • Table Indian Immunologicals Anthrax Vaccines Sales, Price, Value and Gross Profit (2017-2022)

    • Table Indian Immunologicals Anthrax Vaccines Product and Service

    • Table CAVAC (Foundation Year, Company Profile and etc.)

    • Table CAVAC Anthrax Vaccines Sales, Price, Value and Gross Profit (2017-2022)

    • Table CAVAC Anthrax Vaccines Product and Service

    • Table Intervac (Foundation Year, Company Profile and etc.)

    • Table Intervac Anthrax Vaccines Sales, Price, Value and Gross Profit (2017-2022)

    • Table Intervac Anthrax Vaccines Product and Service

    • Table JOVAC (Foundation Year, Company Profile and etc.)

    • Table JOVAC Anthrax Vaccines Sales, Price, Value and Gross Profit (2017-2022)

    • Table JOVAC Anthrax Vaccines Product and Service

    • Table Agrovet (Foundation Year, Company Profile and etc.)

    • Table Agrovet Anthrax Vaccines Sales, Price, Value and Gross Profit (2017-2022)

    • Table Agrovet Anthrax Vaccines Product and Service

    • Table Merial (Foundation Year, Company Profile and etc.)

    • Table Merial Anthrax Vaccines Sales, Price, Value and Gross Profit (2017-2022)

    • Table Merial Anthrax Vaccines Product and Service

    • Table Ceva Santé Animale (Foundation Year, Company Profile and etc.)

    • Table Ceva Santé Animale Anthrax Vaccines Sales, Price, Value and Gross Profit (2017-2022)

    • Table Ceva Santé Animale Anthrax Vaccines Product and Service

    • Table CVCRI (Foundation Year, Company Profile and etc.)

    • Table CVCRI Anthrax Vaccines Sales, Price, Value and Gross Profit (2017-2022)

    • Table CVCRI Anthrax Vaccines Product and Service

    • Table Botswana Vaccine Institute (Foundation Year, Company Profile and etc.)

    • Table Botswana Vaccine Institute Anthrax Vaccines Sales, Price, Value and Gross Profit (2017-2022)

    • Table Botswana Vaccine Institute Anthrax Vaccines Product and Service

    • Table Zoetis (Foundation Year, Company Profile and etc.)

    • Table Zoetis Anthrax Vaccines Sales, Price, Value and Gross Profit (2017-2022)

    • Table Zoetis Anthrax Vaccines Product and Service

    • Table IVPM (Foundation Year, Company Profile and etc.)

    • Table IVPM Anthrax Vaccines Sales, Price, Value and Gross Profit (2017-2022)

    • Table IVPM Anthrax Vaccines Product and Service

    • Table Rosenbusch (Foundation Year, Company Profile and etc.)

    • Table Rosenbusch Anthrax Vaccines Sales, Price, Value and Gross Profit (2017-2022)

    • Table Rosenbusch Anthrax Vaccines Product and Service

    • Table Merck (Foundation Year, Company Profile and etc.)

    • Table Merck Anthrax Vaccines Sales, Price, Value and Gross Profit (2017-2022)

    • Table Merck Anthrax Vaccines Product and Service

    • Table Prondil (Foundation Year, Company Profile and etc.)

    • Table Prondil Anthrax Vaccines Sales, Price, Value and Gross Profit (2017-2022)

    • Table Prondil Anthrax Vaccines Product and Service

    • Table Biogénesis-Bago (Foundation Year, Company Profile and etc.)

    • Table Biogénesis-Bago Anthrax Vaccines Sales, Price, Value and Gross Profit (2017-2022)

    • Table Biogénesis-Bago Anthrax Vaccines Product and Service

    • Table Bayer Sanidad Animal (Foundation Year, Company Profile and etc.)

    • Table Bayer Sanidad Animal Anthrax Vaccines Sales, Price, Value and Gross Profit (2017-2022)

    • Table Bayer Sanidad Animal Anthrax Vaccines Product and Service

    • Table PharmAthene (Foundation Year, Company Profile and etc.)

    • Table PharmAthene Anthrax Vaccines Sales, Price, Value and Gross Profit (2017-2022)

    • Table PharmAthene Anthrax Vaccines Product and Service

    • Table Vecol (Foundation Year, Company Profile and etc.)

    • Table Vecol Anthrax Vaccines Sales, Price, Value and Gross Profit (2017-2022)

    • Table Vecol Anthrax Vaccines Product and Service

    • Table CDV (Foundation Year, Company Profile and etc.)

    • Table CDV Anthrax Vaccines Sales, Price, Value and Gross Profit (2017-2022)

    • Table CDV Anthrax Vaccines Product and Service

    • Table Tiankang (Foundation Year, Company Profile and etc.)

    • Table Tiankang Anthrax Vaccines Sales, Price, Value and Gross Profit (2017-2022)

    • Table Tiankang Anthrax Vaccines Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US